| Literature DB >> 29151049 |
Kenneth Anujuo1, Charles Agyemang1, Marieke B Snijder1, Girardin Jean-Louis2, Bert-Jan van den Born3, Ron J G Peters4, Karien Stronks1.
Abstract
OBJECTIVES: We analysed association between short sleep duration and prevalence of cardiovascular disease (CVD) in a multiethnic population living in the Netherlands, and the contribution of short sleep to the observed ethnic differences in the prevalence of CVD, independent of CVD risk factors.Entities:
Keywords: cardiovascuiar disease; ethnicity; helius study; minority groups; sleep duration
Mesh:
Year: 2017 PMID: 29151049 PMCID: PMC5702024 DOI: 10.1136/bmjopen-2017-017645
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Research model by which short sleep and cardiovascular disease (CVD) risk factors may lead to CVD in various ethnic groups. (A) Short sleep, alongside cardiovascular disease risk factors may lead to cardiovascular disease. (B) Short sleep, independent of cardiovascular disease risk factors may lead to cardiovascular disease.
Characteristics of study population by ethnicity
| Dutch | South-Asian Surinamese | African-Surinamese | Ghanaians | Turks | Moroccans | |
| n=4495 | n=2933 | n=4039 | n=2181 | n=3395 | n=3687 | |
| Age (years) | 46.2 (45.7 to 46.6) | 45.5 (45.0 to 46.0) | 47.9 (47.6 to 48.3) | 44.7 (44.3 to 45.2) | 40.4 (39.9 to 40.8) | 40.4 (40.0 to 40.8) |
| Men (%) | 45.8 (44.4 to 47.3) | 45.3 (43.5 to 47.1) | 39.0 (37.5 to 40.5) | 39.4 (37.3 to 41.4) | 45.4 (43.7 to 47.0) | 38.9 (37.4 to 40.5) |
| Sleep duration (hours) | 7.2 (7.21 to 7.27) | 6.8 (6.70 to 6.81) | 6.5 (6.49 to 6.58) | 6.5 (6.38 to 6.55) | 6.9 (6.92 to 7.04) | 7.0 (6.99 to 7.09) |
| Short sleep (% yes) | 16.2 (15.1 to 17.2) | 39.4 (37.6 to 41.1) | 45.6 (44.0 to 47.1) | 44.2 (42.2 to 46.3) | 29.5 (27.9 to 30.9) | 27.0 (25.6 to 28.4) |
| Angina (% yes) | 1.62 (1.25 to 1.99) | 8.11 (7.12 to 9.10) | 5.45 (4.75 to 6.15) | 5.14 (4.21 to 6.06) | 10.1 (9.09 to 11.1) | 7.35 (6.51 to 8.19) |
| Myocardial infarction | 3.20 (2.69 to 3.72) | 11.4 (10.3 to 12.6) | 8.44 (7.58 to 9.30) | 6.69 (5.64 to 7.74) | 12.2 (11.1 to 13.3) | 10.1 (9.14 to 11.1) |
| Intermittent claudication (% yes) | 0.24 (0.10 to 0.39) | 0.89 (0.55 to 1.22) | 1.02 (0.70 to 1.32) | 1.51 (1.00 to 2.02) | 1.24 (0.86 to 1.61) | 0.87 (0.57 to 1.17) |
| Prevalence CVD (%) | 4.63 (4.01 to 5.24) | 17.0 (15.6 to 18.3) | 12.7 (11.7 to 13.7) | 11.6 (10.3 to 12.9) | 19.9 (18.6 to 21.3) | 15.9 (14.7 to 17.0) |
| Hypertension (% yes) | 29.5 (28.2 to 30.9) | 42.4 (40.6 to 44.2) | 50.2 (48.7 to 51.7) | 55.8 (53.4 to 57.9) | 29.1 (27.6 to 30.4) | 24.4 (22.9 to 25.7) |
| Diabetes (% yes) | 3.58 (3.03 to 4.12) | 19.4 (17.9 to 20.8) | 12.0 (11.0 to 13.0) | 11.4 (10.1 to 12.8) | 10.2 (9.14 to 11.2) | 11.4 (10.3 to 12.4) |
| BMI (kg/m2) | 24.7 (24.6 to 24.9) | 26.3 (26.1 to 26.5) | 27.8 (27.6 to 28.0) | 28.4 (28.2 to 28.6) | 28.5 (28.3 to 28.7) | 27.6 (27.4 to 27.7) |
| WHR | 0.88 (0.87 to 0.88) | 0.92 (0.92 to 0.93) | 0.89 (0.89 to 0.90) | 0.90 (0.90 to 0.91) | 0.90 (0.90 to 0.91) | 0.89 (0.89 to 0.90) |
| Dyslipidaemia (% yes) | 29.9 (28.5 to 31.2) | 41.7 (39.9 to 43.4) | 24.0 (22.7 to 25.3) | 20.1 (18.4 to 21.7) | 40.8 (39.1 to 42.4) | 27.6 (26.1 to 29.0) |
| TC | 15.3 (14.2 to 16.3) | 11.7 (10.5 to 12.8) | 9.73 (8.82 to 10.6) | 10.5 (9.21 to 11.8) | 8.84 (7.89 to 9.79) | 4.83 (4.14 to 5.52) |
| HDL-C | 9.77 (8.90 to 10.6) | 22.9 (21.4 to 24.5) | 11.0 (10.0 to 11.9) | 6.75 (5.69 to 7.79) | 26.5 (24.9 to 27.9) | 18.7 (17.4 to 19.9) |
| LDL-C | 13.7 (12.7 to14.7) | 14.3 (13.0 to 15.5) | 10.5 (9.58 to 11.5) | 10.6 (9.35 to 11.9) | 10.1 (9.09 to 11.1) | 5.86 (5.10 to 6.62) |
| TG | 11.9 (10.9 to 12.8) | 16.9 (15.5 to 18.2) | 5.67 (4.96 to 6.38) | 3.35 (2.59 to 4.10) | 20.1 (18.8 to 21.5) | 10.6 (9.59 to 11.6) |
| Depressive symptoms (%) | 6.99 (6.24 to 7.73) | 18.4 (16.9 to 19.8) | 10.6 (9.67 to 11.6) | 9.08 (7.87 to 10.3) | 22.8 (21.3 to 24.2) | 20.3 (18.9 to 21.6) |
| Education | ||||||
| First and second category (%) | 17.3 (16.2 to 18.4) | 47.8 (46.0 to 49.6) | 40.8 (39.3 to 42.3) | 68.0 (66.1 to 70.0) | 55.9 (54.3 to 57.6) | 48.7 (47.1 to 50.3) |
| Third category (%) | 21.7 (20.5 to 22.9) | 29.0 (27.4 to 30.7) | 35.9 (34.4 to 37.4) | 25.6 (23.7 to 27.4) | 28.7 (27.1 to 30.2) | 33.3 (31.8 to 34.9) |
| Fourth category (%) | 60.9 (59.5 to 62.4) | 23.2 (21.6 to 24.7) | 23.2 (21.9 to 24.5) | 6.37 (5.34 to 7.40) | 15.4 (14.2 to 16.6) | 17.9 (16.7 to 19.2) |
| Occupation | ||||||
| Elementary (%) | 1.65 (1.27 to 2.02) | 9.48 (8.42 to 10.5) | 6.29 (5.54 to 7.04) | 53.7 (51.6 to 55.8) | 14.9 (13.7 to 16.1) | 12.9 (11.9 to 14.0) |
| Lower (%) | 14.1 (13.1 to 15.1) | 30.7 (29.0 to 32.3) | 31.9 (30.4 to 33.3) | 20.2 (18.5 to 21.8) | 30.5 (28.9 to 32.1) | 24.8 (23.4 to 26.2) |
| Medium (%) | 21.9 (20.7 to 23.2) | 27.4 (25.8 to 29.0) | 32.3 (30.9 to 33.8) | 7.79 (6.67 to 8.92) | 18.8 (17.5 to 20.1) | 21.1 (19.8 to 22.3) |
| Higher (%) | 36.4 (35.0 to 37.8) | 16.1 (14.8 to 17.5) | 17.8 (16.6 to 19.0) | 2.57 (1.90 to 3.23) | 8.45 (7.52 to 9.39) | 11.5 (10.5 to 12.5) |
| Scientific (%) | 19.9 (18.7 to 21.0) | 4.67 (3.91 to 5.43) | 2.62 (2.13 to 3.12) | 0.87 (0.48 to 1.26) | 3.21 (2.62 to 3.80) | 2.36 (1.87 to 2.85) |
| Shift work (%) | 19.4 (18.2 to 20.5) | 21.9 (20.4 to 23.4) | 26.8 (25.4 to 28.1) | 17.1 (15.5 to 18.7) | 14.0 (12.9 to 15.2) | 14.7 (13.6 to 15.9) |
| Smoking status | ||||||
| Never smoked (% yes) | 37.1 (35.7 to 38.5) | 57.9 (56.2 to 59.7) | 48.9 (47.4 to 50.5) | 86.7 (85.3 to 88.1) | 47.4 (45.7 to 49.1) | 73.9 (72.5 to 75.3) |
| Ex-smoker (% yes) | 38.1 (36.7 to 39.5) | 13.7 (12.5 to 14.9) | 19.3 (18.1 to 20.5) | 8.30 (7.14 to 9.46) | 18.3 (17.0 to 19.6) | 12.7 (11.6 to 13.8) |
| Current smoker (% yes) | 24.6 (23.4 to 25.9) | 27.9 (26.3 to 29.6) | 31.2 (29.8 to 32.7) | 4.49 (3.62 to 5.36) | 33.6 (32.0 to 35.2) | 13.0 (11.9 to 14.1) |
| Achieving Dutch norm for physical activity (% yes) | 75.5 (74.3 to 76.8) | 53.2 (51.4 to 54.9) | 61.2 (59.7 to 62.7) | 54.2 (52.1 to 56.3) | 42.5 (40.8 to 44.2) | 47.2 (45.6 to 48.8) |
| Alcohol intake (% yes) | 91.2 (90.4 to 92.0) | 56.7 (54.9 to 58.5) | 68.8 (67.4 to 70.2) | 48.1 (45.9 to 50.2) | 22.9 (21.5 to 24.3) | 7.18 (6.35 to 8.02) |
Data are presented as means and percentages with 95% CI.
BMI, body mass index; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoproptein cholesterol; TC, total cholesterol; TG, triglyceride; WHR, waist to hip ratio.
Figure 2Crude association between sleep duration and prevalence of CVD among ethnic groups in Amsterdam. CVD, cardiovascular disease.
PRs for the relationship between sleep duration (short sleep vs healthy sleep) and the prevalence of CVD by ethnicity
| Dutch, | South-Asian Surinamese, n=2933 | African-Surinamese, | Ghanaians, | Turks, | Moroccans, | |
| PR (95% CI) | PR (95% CI) | PR (95% CI) | PR (95% CI) | PR (95% CI) | PR (95% CI) | |
| Short sleep | ||||||
| Crude | 2.05 (1.54 to 2.75)*** | 1.67 (1.42 to 1.96)*** | 1.52 (1.29 to 1.79)*** | 1.46 (1.16 to 1.85)* | 1.56 (1.36 to 1.79)*** | 1.44 (1.24 to 1.68)*** |
| Model 1 | 1.84 (1.38 to 2.46)*** | 1.59 (1.35 to 1.87)*** | 1.56 (1.32 to 1.84)*** | 1.54 (1.22 to 1.95)*** | 1.51 (1.32 to 1.73)*** | 1.39 (1.19 to 1.63)*** |
| Model 2 | 1.62 (1.20 to 2.18)* | 1.53 (1.31 to 1.79)*** | 1.51 (1.28 to 1.78)*** | 1.55 (1.22 to 1.97)*** | 1.46 (1.27 to 1.68)*** | 1.41 (1.21 to 1.65)*** |
Model 1: adjusted for age and sex.
Model 2: adjusted for model 1 plus BMI, WHR, hypertension, diabetes, dyslipidaemia, smoking, alcohol consumption and physical activity.
*P<0.05; ***P<0.001.
BMI, body mass index; CVD, cardiovascular disease; PRs, prevalence ratios; WHR, waist to hip ratio.
PRs for ethnic differences in prevalence CVD, adjusting for short sleep and CVD risk factors separately and simultaneously
| Confounders | Confounders+short sleep | Confounders+CVD risk factors | Confounders+short sleep, CVD risk factors | Difference in (%) reduction between models 4 and 3 | ||||
| Ethnic group | PR | PR | Reduction PR total short sleep (%)† | PR | Reduction PR total CVD risk factors (%)‡ | PR | Reduction PR total short sleep, total CVD risk factors (%)§ | Difference in reduction (%)¶ |
| Dutch | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| South-Asian Surinamese | 3.69 (3.16 to 4.31)*** | 3.31 (2.83 to 3.87)*** | 14 | 3.05 (2.59 to 3.59)*** | 24 | 2.78 (2.36 to 3.28)*** | 34 | 10 |
| African-Surinamese | 2.64 (2.26 to 3.08)*** | 2.32 (1.98 to 2.72)*** | 19 | 2.24 (1.91 to 2.63)*** | 24 | 2.00 (1.70 to 2.36)*** | 39 | 15 |
| Ghanaians | 2.54 (2.13 to 3.02)*** | 2.23 (1.87 to 2.67)*** | 20 | 2.24 (1.85 to 2.69)*** | 19 | 2.02 (1.67 to 2.43)*** | 34 | 15 |
| Turks | 4.64 (4.00 to 5.39)*** | 4.31 (3.71 to 5.00)*** | 9 | 3.76 (3.18 to 4.45)*** | 24 | 3.57 (3.02 to 4.23)*** | 29 | 5 |
| Moroccans | 3.63 (3.12 to 4.22)*** | 3.40 (2.92 to 3.96)*** | 8 | 3.37 (2.84 to 4.00)*** | 10 | 3.23 (2.72 to 3.84)*** | 15 | 5 |
Model 1: confounders: adjusted for age and gender.
Model 2: adjusted for age, gender and short sleep.
Model 3: adjusted for age, gender and CVD risk factors.
Model 4: adjusted for age, gender, CVD risk factors and short sleep.
***P<0.001.
†Contribution of short sleep: reduction in PRs (%) between model 1 and model 2.
‡Contribution of CVD risk factors: reduction in PRs (%) between model 1 and model 3.
§Contribution of both CVD risk factors and short sleep: reduction in PRs (%) between model 1and model 4.
¶Contribution of short sleep independent of CVD risk factors; difference in PRs reduction (%) between model 3 and model 4.
CVD, cardiovascular disease; PRs, prevalence ratios.